Viking Global Investors
Overview
Viking Global Investors is a global investment firm founded in 1999 that manages capital across long/short, long-only, liquid-illiquid, illiquid, and hybrid credit and structured capital strategies. The firm performs fundamental analysis to identify attractive investments in companies located around the world.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Candid Therapeutics | Mar 2026 | PIPE | Co-investor |
| Antheia | Jan 2026 | Series C | Co-investor |
| Diagonal Therapeutics | Jan 2026 | Series B | Co-investor |
| Allonnia | Dec 2025 | Series A Extension | Lead |
| Galecto Biotech | Nov 2025 | Private Placement | Co-investor |
Key People
David Ott
Co-Founder And Advisory Director
Andreas Halvorsen
Co-Founder And CEO
Hans Reuter
Managing Director, Private Investments
Brent Kirshner
Principal
Emily Nolop
Principal - Private Investments
Erina Shan
Principal
Josh Rowley
Principal, Private Investments
Levi Malik
Principal, Private Investments
Maneka Mirchandaney
Principal
Michael Schwartz
Principal
Mihir Jain
Principal, Private Investments
Sterling Sipp
Principal, Private Investments
Tom Cerabona
Principal Technology Product Manager
Hani Sabbagh
Portfolio Manager
James L.
Portfolio Manager
Justin Walsh
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
